CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2012

View the entire original 990 at ProPublica ↗

Organization: CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
Tax period: 2012-01-01 to 2012-12-31
Filed: 2013-08-09
IRS object ID: 201332219349301028
Schema version: 2012v2.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2013-08-09T13:22:05-05:00	Timestamp
Tax Period End Date	2012-12-31	TaxPeriodEndDate

Preparer Firm PreparerFirm

Field	Value	IRS element (for citing)
EIN	521855942	EIN

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	TATE AND TRYON	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	2021 L STREET NW SUITE 400	AddressLine1
City	WASHINGTON	City
State	DC	State
ZIP Code	20036	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2012-01-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	311667995	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF THE	BusinessNameLine1
Business Name Line2	AMERICAN SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine2

Field	Value	IRS element (for citing)
Name Control	CONQ	NameControl
Phone	5714831700	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	PAUL AINES	Name
Title	CFO	Title
Phone	5714831300	Phone
Date Signed	2013-08-09	DateSigned
Authorize Third Party	1	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Name	DEBORAH G KOSNETT	Name
PTIN	P00290720	PTIN
Phone	2022932200	Phone

Field	Value	IRS element (for citing)
Tax Year	2012	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	ALLEN LICHTER MD	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	44268960	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	WWW.CONQUERCANCERFOUNDATION.ORG	WebSite
Type Of Organization Trust	X	TypeOfOrganizationTrust
Year Formation	1999	YearFormation
State Legal Domicile	VA	StateLegalDomicile
Activity Or Mission Description	THE MISSION STATEMENT FOR CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS: CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	14	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	13	NbrIndependentVotingMembers
Total Nbr Employees	0	TotalNbrEmployees
Total Nbr Volunteers	130	TotalNbrVolunteers
Total Gross UBI	0	TotalGrossUBI
Net Unrelated Business Txbl Income	0	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	23070515	ContributionsGrantsPriorYear
Contributions Grants Current Year	25403476	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	0	ProgramServiceRevenuePriorYear
Program Service Revenue CY	0	ProgramServiceRevenueCY
Investment Income Prior Year	902480	InvestmentIncomePriorYear
Investment Income Current Year	1387836	InvestmentIncomeCurrentYear
Other Revenue Prior Year	0	OtherRevenuePriorYear
Other Revenue Current Year	0	OtherRevenueCurrentYear
Total Revenue Prior Year	23972995	TotalRevenuePriorYear
Total Revenue Current Year	26791312	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	16237145	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	16299020	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	0	SalariesEtcPriorYear
Salaries Etc Current Year	0	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	534850	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	110025	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	2034840	TotalFundrsngExpCurrentYear
Other Expense Prior Year	3999492	OtherExpensePriorYear
Other Expenses Current Year	4338161	OtherExpensesCurrentYear
Total Expenses Prior Year	20771487	TotalExpensesPriorYear
Total Expenses Current Year	20747206	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	3201508	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	6044106	RevenuesLessExpensesCY
Total Assets BOY	36980488	TotalAssetsBOY
Total Assets EOY	43383551	TotalAssetsEOY
Total Liabilities BOY	8631006	TotalLiabilitiesBOY
Total Liabilities EOY	8230445	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	28349482	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	35153106	NetAssetsOrFundBalancesEOY
Info In Schedule O Part III	X	InfoInScheduleOPartIII
Mission Description	THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) WAS STARTED BY CANCER DOCTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), TO FIGHT AND CONQUER ALL TYPES OF CANCER WORLDWIDE. CCF SEEKS DRAMATIC ADVANCES IN THE PREVENTION, TREATMENT AND CURE OF CANCER ALL TYPES OF CANCER WHEREVER THEY OCCUR BY FUNDING BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS.WE RAISE FUNDS TO SUPPORT CANCER RESEARCH AND TO SUPPORT THE LIFESAVING WORK OF ASCO AND ITS GLOBAL NETWORK OF 30,000 ONCOLOGY PROFESSIONALS IN 100 COUNTRIES. THESE PHYSICIANS AND RESEARCHERS ARE THE WORLD'S PREEMINENT CANCER SPECIALISTS-THE PEOPLE WHO CHALLENGE CANCER EVERY DAY, USING TREATMENTS BORN OF VISIONARY RESEARCH. PEOPLE WHO ARE WELL ACQUAINTED WITH THE HUMAN COST OF DISEASE - AND SEE THE VAST SCIENTIFIC AND CLINICAL OPPORTUNITIES FOR CONQUERING CANCER. IN THIS WAY, EVERY PATIENT WHO SEES AN ONCOLOGIST HAS BEEN TOUCHED BY US.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	10369463	Expense
Grants	9743520	Grants
Description	PROFESSIONAL EDUCATION - WE HELP ONCOLOGISTS WORLDWIDE STAY UP TO DATE ON THE LATEST DEVELOPMENTS AND DISCOVERIES IN CANCER KNOWLEDGE. THE CCF SUPPORTS THE EFFORTS OF ASCO TO PROVIDE THE LATEST KNOWLEDGE AND PROVIDE EDUCATION TO PHYSICIANS, RESEARCHERS AND CAREGIVERS AROUND THE WORLD. THIS WORK PROVIDES A DIRECT IMPACT AND BENEFIT TO EVERY CANCER PATIENT IN THE U.S. AND AROUND THE WORLD BY DEVELOPING AND COMMUNICATING THE MOST ADVANCED TREATMENT PROTOCOLS DEVELOPED BY ASCO PHYSICIANS. FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS.HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2012 INCLUDE:* THE ASCO ANNUAL MEETING FEATURED MORE THAN 200 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 4,500 ABSTRACTS WERE PRESENTED OR PUBLISHED. NEARLY 3,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY. THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTS OVER 31,000 ATTENDEES WORLDWIDE. THE MEETING IS DESIGNED TO ADVANCE THE EDUCATION OF PHYSICIANS AND OTHER PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE, TO SUPPORT THE DEVELOPMENT OF CLINICAL CANCER RESEARCHERS AND TO FACILITATE THE DELIVERY OF HIGH-QUALITY HEALTH CARE TO PATIENTS WITH CANCER. SCIENTIFIC AND EDUCATIONAL SESSIONS ARE DESIGNED TO PROVIDE MEETING ATTENDEES OPTIMUM LEARNING EXPERIENCES THROUGH DISEASE-SPECIFIC TOPICS AND ONCOLOGY-RELATED SUBJECTS.* QUALITY CARE SYMPOSIUM IS A TWO-DAY NATIONAL SYMPOSIUM FOCUSING ON INNOVATIVE STRATEGIES TO ADVANCE THE AREAS OF QUALITY MEASUREMENT, QUALITY IMPROVEMENT, PATIENT OUTCOMES, COMPARATIVE EFFECTIVENESS RESEARCH AND THE ELIMINATION OF DISPARITIES IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER IN THE UNITED STATES. THE OVERARCHING GOAL IS TO IMPROVE THE HEALTH OF ALL INDIVIDUALS WITH CANCER, THOSE AT INCREASED RISK OF DEVELOPING CANCER, AND CANCER SURVIVORS.* GASTROINTESTINAL CANCERS (GI) SYMPOSIUM - THE ANNUAL GI SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY.* GENITOURINARY CANCERS (GU) SYMPOSIUM - THE ANNUAL GU SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETYOF UROLOGIC ONCOLOGY.* BREAST CANCER (BCS) SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THIS SYMPOSIUM OFFERS AN OPPORTUNITY FOR CLINICALLY RELEVANT, IN-DEPTH DISCUSSIONS OF HOW AND WHEN TO TRANSLATE NEW FINDINGS INTO PATIENT CARE ULTIMATELY TO IMPROVE OUTCOMES FOR PATIENTS REQUIRING BREAST CANCER THERAPY. THE MEETING IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., THE SOCIETY OF SURGICAL ONCOLOGY.* BEST OF ASCO HELD IN CHICAGO, IL, BOSTON, MA, AND SAN DIEGO, CA- THE BEST OF ASCO MEETING PROGRAM CONDENSES HIGHLIGHTS FROM THE ASCO ANNUAL MEETING INTO A TWO DAY EDUCATIONAL MEETING, WHICH PROVIDES A UNIQUE, INTIMATE FORUM FOR THE PRESENTATION AND DISCUSSION OF THE PRACTICE-CHANGING SCIENCE AND EDUCATIONAL HIGHLIGHTS THAT WERE PRESENTED. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. THIS PROGRAM PROVIDES ACCESS TO THE MOST CUTTING-EDGE, PRACTICE-CHANGING RESEARCH PRESENTED AT THE MEETING IN A RESPONSIBLE, PEER-REVIEWED MANNER.* ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN PARTNERSHIP WITH THE AMERICAN ASSOCIATION OF CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL CANCER TYPES. THE WORKSHOP TEACHES ATTENDEES HOW TO PLAN AND CONDUCT AN EFFECTIVE CLINICAL TRIAL . THE OVERALL GOAL OF THE WORKSHOP IS TO INCREASE THE RELIABILITY AND EFFECTIVENESS OF CLINICAL TRIALS ULTIMATELY LEADING TO BETTER PATIENT CARE.MARKERS IN CANCER: A JOINT MEETING BY ASCO, EORTC AND NCI THE PURPOSE OF THE MARKERS IN CANCER MEETING IS TO ACCELERATE PROGRESS IN THE FIGHT AGAINST CANCER BY IMPROVING INTERNATIONAL SCIENTIFIC COLLABORATION BETWEEN EUROPE AND THE UNITED STATES AND AMONG RESEARCHERS AND CLINICIANS, AND FOSTER A PATIENT CENTERED APPROACH TO TRANSLATING CLINICALLY USEFUL INFORMATION FROM THE LABORATORY BENCH TO THE BEDSIDE. THIS MEETING IS AN IMPORTANT VENUE FOR THE DISCUSSION OF CONTEMPORARY ISSUES SURROUNDING BIOMARKERS. PRIOR TO THE MAIN MEETING, A ONE AND A HALF-DAY TUTORIAL OPEN TO SELECTED ATTENDEES IS HELD TO PROVIDE CLINICAL DECISION-MAKING TOOLS AND DIAGNOSTIC CHALLENGES IN AN INTERACTIVE, TEAM-BASED FORMAT WITH DISCUSSIONS AND LECTURES LED BY DISTINGUISHED FACULTY.HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2012 INCLUDE:PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT COSPONSORED THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED.EDUCATIONAL BOOKS -THE ASCO ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS FROM THE ASCO ANNUAL MEETING, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON. ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995.VIRTUAL MEETINGS ON ASCO.ORG - THE VIRTUAL MEETINGS WEBSITE USES THE LATEST TECHNOLOGY TO PROVIDE THE RESULTS OF THE LATEST CANCER SCIENTIFIC AND EDUCATION INFORMATION TO HEALTHCARE PROFESSIONALS INVOLVED IN CANCER CARE. EACH SESSION INCLUDED ON THE VIRTUAL MEETINGS HAS ITS OWN OBJECTIVES. VIRTUAL MEETINGS USES THE LATEST TECHNOLOGY TO ALLOW USERS TO VIEW AND REVIEW SESSIONS THE VIRTUAL MEETING FEATURES MORE THAN 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC SYMPOSIA DATING BACK FIVE YEARS - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA (SLIDES AND AUDIO) LECTURES AVAILABLE ONLINE.ONLINE PORTALS - ASCO WEBSITES PROVIDE FAST, EASY NAVIGATION AND ADVANCED SEARCH CAPABILITIES. THE ASCO ONLINE PLATFORM HOSTS DISEASE-SPECIFIC PORTAL SITES. THESE "CANCER PORTALS" ARE ORGANIZED THEMATICALLY TO ALLOW SITE USERS TO EASILY ACCESS THE WEALTH OF DISEASE-SPECIFIC INFORMATION AVAILABLE. THE CANCER PORTALS ARE THE PRODUCT OF A COLLABORATION BETWEEN ASCO, JCO, AND HIGHWIRE PRESS - AN EPUBLISHING DIVISION OF THE STANFORD UNIVERSITY LIBRARIES, WHICH PRODUCES ONLINE VERSIONS OF PEER-REVIEWED JOURNALS AND SCHOLARLY CONTENT.ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE PLATFORM THAT PROVIDES EDUCATION FOR ONCOLOGY PROFESSIONALS. COURSE CONTENT IS DEVELOPED AND PRESENTED BY RECOGNIZED EXPERTS. ASCO UNIVERSITY SERVES AS THE EDUCATIONAL HOME AND SOURCE FOR SELFDIRECTED LEARNING ACTIVITIES FOR PRACTICING ONCOLOGISTS AND THE NEXT GENERATION OF FELLOWS AND RESIDENTS. THE ACTIVITIES ON ASCO UNIVERSITY INCORPORATE FLEXIBLE, ROBUST CURRICULA WITH COLLATERAL PRODUCTS THAT TRANSLATE KEY ADULT LEARNING PRINCIPLES INTO INTERACTIVE EDUCATIONAL EXPERIENCES.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	7039611	Expense
Grants	6176000	Grants
Description	RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES RELIES ON FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. CCF PRIDES ITSELF ON ITS SCIENTIFIC RIGOR, RESULTING FROM A MULTISTAGE PEER REVIEW PROCESS AND THE PARTICIPATION OF GLOBALLY RECOGNIZED SCIENTISTS, ONCOLOGISTS, AND BIOSTATISTICIANS IN THE SELECTION OF MERITORIOUS RESEARCH FOR FUNDING. SINCE 1984, CCF AND ASCO HAVE FUNDED MORE THAN $77 MILLION IN CANCER RESEARCH GRANTS TO MORE THAN 975 RECIPIENTS. IN 2012, CCF AWARDED 66 RESEARCH GRANTS. CCF FUNDS THE ENTIRE SPECTRUM OF CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND AS A CHARITABLE ORGANIZATION, SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS.HIGHLIGHTS OF 2012 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE:ADVANCED CLINICAL RESEARCH AWARD (ACRA)- $450,000 PROVIDED ONE (1)THREE-YEAR AWARD INTENDED TO FUND AN INVESTIGATOR COMMITTED TO CLINICAL CANCER RESEARCH AND WHO IS CONDUCTING ORIGINAL RESEARCH IN BREAST CANCER.DRUG DEVELOPMENT RESEARCH PROFESSORSHIP AWARD (DDRP)- $500,000 PROVIDED A FIVE-YEAR GRANT DESIGNED TO PROVIDE FLEXIBLE FUNDING TO AN OUTSTANDING RESEARCHER WHO HAS MADE, AND IS CONTINUING TO MAKE, SIGNIFICANT CONTRIBUTIONS IN DRUG DEVELOPMENT THAT HAVE CHANGED THE DIRECTION OF CANCER RESEARCH, AND WHO PROVIDES MENTORSHIP TO FUTURE DRUG DEVELOPMENT RESEARCHERS. THIS GRANT IS INTENDED TO SUPPORT QUALIFIED INDIVIDUALS WHO ARE DEDICATED TO BRINGING ADVANCES INTO THE CLINICAL ARENA BY EXPLORING NEW AND PROMISING THERAPEUTIC COMPOUNDS THAT WILL LEAD TO IMPROVED TREATMENTS, AND TO MENTORING OTHER RESEARCHERS IN THE SCIENTIFIC AND REGULATORY ASPECTS OF DRUG DEVELOPMENT.CAREER DEVELOPMENT AWARD (CDA)- $2,200,000 PROVIDED ELEVEN (11)THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENT AND ARE ESTABLISHING AN INDEPENDENT CLINICAL CANCER RESEARCH PROGRAM.YOUNG INVESTIGATOR AWARD (YIA)- $2,275,000 PROVIDED FOURTY-SIX (46)ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT.LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE)- $230,000 PROVIDED TWO (2) ONE-YEAR FELLOWSHIPS TO EARLY-CAREER ONCOLOGISTS FROM A LOW TO MIDDLE INCOME COUNTRY FOR THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION.GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP- $50,000 PROVIDED A ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENTTHE JAMES B. NACHMAN JUNIOR FACULTY AWARD IN PEDIATRIC ONCOLOGY WAS ESTABLISHED IN MEMORY OF JAMES B. NACHMAN, MD, AN INTERNATIONALLY RENOWNED PEDIATRIC CANCER EXPERT AND PEDIATRICS PROFESSOR. HE CHAIRED SEVERAL CHILDREN'S ONCOLOGY GROUP NATIONAL STUDY COMMITTEES AND WAS AN AUTHORITY IN THE MEDICAL MANAGEMENT OF CHILDHOOD CANCERS, ESPECIALLY LEUKEMIA AND LYMPHOMA. $6,000 PROVIDED FOR TWO JUNIOR FACULTY MEMBERS WITH THE HIGHEST-SCORING ABSTRACTS IN PEDIATRIC ONCOLOGY TO PRESENT THE ABSTRACTS AT THE ASCO ANNUAL MEETING.CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- $18,000 PROVIDED A PROGRAM THAT PUBLICLY HONORS HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES.MERIT AWARDS- $222,000 PROVIDED FOR THE BRADLEY STUART BELLER MERIT AWARD AND 191 MERIT AWARDS WHICH PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA. ONCOLOGY TRAINEE TRAVEL AWARDS- $21,000 PROVIDED FOR 17 TRAVEL AWARDS TO ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANT TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING. CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2012 INCLUDED:GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM.BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE MEDICAL EDUCATION, AND ASSIST IN CAREER DEVELOPMENT. IDEA RECIPIENTS SHARE THE KNOWLEDGE AND TRAINING THEY RECEIVED THROUGH THE PROGRAM WITH COLLEAGUES IN THEIR HOME COUNTRIES ONCE THEY RETURN. ON AVERAGE, EACH IDEA ALUMNUS SHARES THE INFORMATION AND NEW SKILLS THEY LEARNED WITH 50 COLLEAGUES IN HIS OR HER COUNTRY. IDEA ALUMNI HAVE ASSUMED LEADERSHIP POSITIONS ON ASCO COMMITTEES, RECEIVED FELLOWSHIPS AND OTHER RESEARCH OPPORTUNITIES, AND PURSUED LONGER-TERM COLLABORATIONS WITH THEIR MENTORS.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	249100	Expense
Grants	245500	Grants
Description	QUALITY AND ACCESS TO CARE REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CCF IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CCF IN 2012 INCLUDE:CANCERLINQ IS AN INITIATIVE TO DEVELOP A RAPID LEARNING SYSTEM IN ONCOLOGY. THIS EFFORT IS INTENDED TO TRANSFORM THE WAY ONCOLOGISTS PRACTICE, LEARN, AND INTERACT WITH THEIR PATIENTS. THE ASSESSMENT PHASE FOCUSES ON THE DEVELOPMENT OF A BREAST-CANCER SPECIFIC PROTOTYPE, WHICH WILL HELP DETERMINE AND OVERCOME THE BARRIERS IN DEVELOPING A FULL SYSTEM.STATE/REGIONAL AFFILIATE PROGRAM - THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS ISSUES IN THE PRACTICE OF ONCOLOGY ON THE LOCAL LEVEL. THE PROGRAM INCLUDES FACILITATION OF INTERACTION AMONG ASCO AND 48 STATE OR REGIONAL ONCOLOGY SOCIETIES THAT HAVE ACCESS TO THE SOCIETY'S EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL. DIVERSITY IN ONCOLOGY INITIATIVE - THE CONQUER CANCER FOUNDATION GRANTS AND AWARDS PROGRAM OFFERS OR PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE, FUNDED BY SUSAN G. KOMEN FOR THE CURE(R). THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. IN 2012, $112,500 PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD:MEDICAL STUDENT ROTATION - THE MEDICAL STUDENT ROTATION (MSR), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2012, $85,000 PROVIDED 10 MSRS.RESIDENT TRAVEL AWARD - THE RESIDENT TRAVEL AWARD PROVIDES FINANCIAL SUPPORT FOR RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND ASCO'S ANNUAL MEETING. THE INTENTION OF THIS AWARD IS TO ATTRACT RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO A POSSIBLE CAREER IN ONE OF THE ONCOLOGY SPECIALTIES. THIS TRAVEL AWARD WILL ALLOW THE RECIPIENTS TO TRAVEL TO THE ASCO ANNUAL MEETING, WHERE THEY WILL HAVE AN OPPORTUNITY TO MEET ONCOLOGISTS AND TO UNDERSTAND THE CAREER POSSIBILITIES IN THE AREA. IN 2012, $10,500 FUNDED 7 RTAS. ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES. THE DIVERSITY IN ONCOLOGY INITIATIVE WAS DEVELOPED AS PART OF THE SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE, WHICH IS DESIGNED TO SUPPORT SPECIFIC PROJECTS ADDRESSING QUALITY CANCER CARE ISSUES, INCLUDING CANCER WORKFORCE, ACCESS TO CARE, DISPARITIES, CLINICAL TRIALS, AND SURVIVORSHIP, WITH GENERAL APPLICABILITY TO BREAST CANCER.	Description

Activity Other ActivityOther

Field	Value	IRS element (for citing)
Expense	280564	Expense
Grants	134000	Grants
Description	PATIENT EDUCATION AND INFORMATION - WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS.HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2012 INCLUDE:PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. IN 2012, $134,000 ALLOWED 72 PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS.CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS BY THE CANCER.NET EDITORIAL BOARD, COMPOSED OF MORE THAN 150 MEDICAL, SURGICAL, RADIATION, AND PEDIATRIC ONCOLOGISTS, PHYSICIAN ASSISTANTS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENT ADVOCATES AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST , TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2012, THERE WERE MORE THAN 10,000,000 PAGE VIEWS OF CANCER.NET. CANCER.NET CELEBRATED ITS 10TH ANNIVERSARY IN MAY 2012.CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT INFORMATION MATERIALS, SUCH AS:ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. CURRENT DISEASE-SPECIFIC FACT SHEETS INCLUDE: BREAST, COLORECTAL, LUNG, AND PROSTATE CANCERS AND ARE ALSO AVAILABLE IN SPANISH. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR. PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAINING COMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS,AND AFTER TREATMENT. ONCOLOGY PROFESSIONALS AND PATIENTS EXPLORE THESE CANCER-SPECIFIC BOOKLETS TOGETHER AFTER A DIAGNOSIS OF CANCER. THERE ARE BOOKLETS FOR THE FOUR MOST COMMON TYPES OF CANCER IN THE UNITED STATES: BREAST, COLORECTAL, LUNG, PROSTATE AND ARE AVAILABLE IN ENGLISH AND SPANISH.INTERNATIONAL PROGRAMS ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. CCF FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION AND INFORMATION AND QUALITY AND ACCESS TO CARE).CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE:LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE YEAR FELLOWSHIP THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT.ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS.	Description

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	280564	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	134000	TotalOfOtherProgramServiceGrnt
Total Program Service Expense	17938738	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	0	LobbyingActivities
Subject To Proxy Tax	0	SubjectToProxyTax
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	0	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	1	TermOrPermanentEndowments
Report Land Bldg Equip	0	ReportLandBldgEquip
Report Invest Oth Securities	0	ReportInvestOthSecurities
Report Prog Rel Invest	0	ReportProgRelInvest
Report Other Assets	0	ReportOtherAssets
Report Other Liabilities	1	ReportOtherLiabilities
Report Fin48 Footnote	1	ReportFin48Footnote
Independent Audit Financial Stmt	1	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	1	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	1	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	0	FundraisingActivities
Gaming	0	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	1	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	0	TaxExemptBonds
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	0	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	0	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	0	DeductibleNonCashContributions
Deductible Contributions Of Art	0	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	0	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	0	RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	170	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	1	ComplianceWithBackupWitholding
Number Of Employees	0	NumberOfEmployees
Unrelated Business Income	0	UnrelatedBusinessIncome
Foreign Financial Account	0	ForeignFinancialAccount
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	0	QuidProQuoContributions
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Indoor Tanning Services	0	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	14	NbrVotingGoverningBodyMembers
Number Independent Voting Members	13	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	0	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	0	MembersOrStockholders
Election Of Board Members	1	ElectionOfBoardMembers
Decisions Subject To Approval	1	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	0	LocalChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
Own Website	X	OwnWebsite

The Books Are In Care Of TheBooksAreInCareOf

Field	Value	IRS element (for citing)
Name Person	PAUL AINES CFO	NamePerson
Telephone Number	5714831300	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	SAME AS C ABOVE	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (18 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Average Hours Per Week RelatedAverageHoursPerWeekRelated	Individual Trustee Or DirectorIndividualTrusteeOrDirector	OfficerOfficer	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation
MARTIN J MURPHY DMEDSC PHD
CHAIR	1.00	1.00	X	X	0	0	0
W CHARLES PENLEY MD FASCO
TREASURER	1.00	0.00	X	X	0	0	0
RICHARD SCHILSKY MD FASCO
SECRETARY	1.00	0.00	X	X	0	0	0
ALLEN S LICHTER MD FASCO
CEO	4.00	33.50	X	X	0	779040	20624
NANCY DALY MS MPH
EXECUTIVE DIRECTOR	37.50	0.00	X	X	0	212312	30150
SANDRA M SWAIN MD
ASCO PRESIDENT	1.00	1.00	X		0	0	0
LAWRENCE H EINHORN MD FASCO
BOARD MEMBER	1.00	0.00	X		0	1500	0
IRA M ELEGANT ESQ
BOARD MEMBER	1.00	0.00	X		0	0	0
JOHN H GLICK MD FASCO
BOARD MEMBER	1.00	0.00	X		0	0	0
MICHAEL GORDON JD
BOARD MEMBER	1.00	0.00	X		0	0	0
GABRIEL N HORTOBAGYI MDFACPFASCO
BOARD MEMBER	1.00	0.00	X		0	0	0
NORA A JANJANMDMPSAMBAFASCO
BOARD MEMBER	1.00	0.00	X		0	0	0
BETH Y KARLAN MD
BOARD MEMBER	1.00	0.00	X		0	0	0
THOMAS A MARSLAND MD FASCO
BOARD MEMBER	1.00	0.00	X		0	0	0
ROBERT J MAYER MD FASCO
BOARD MEMBER	1.00	0.00	X		0	0	0
THOMAS G ROBERTS JR MD
BOARD MEMBER	1.00	0.00	X		0	0	0
DINA MICHELS ESQ
GENERAL COUNSEL	4.00	33.50		X	0	473165	38214
PAUL AINES CPA
CFO	4.00	33.50		X	0	300127	37292

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	0	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	1766144	TotalReportableCompFrmRltdOrgs
Total Other Compensation	126280	TotalOtherCompensation
Number Individuals GT100 K	0	NumberIndividualsGT100K
Formers Listed	0	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation

Name Of Contractor NameOfContractor

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	GRAHAM PELTON	BusinessNameLine1

Address Of Contractor AddressOfContractor

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	39 BEACHWOOD ROAD	AddressLine1
City	SUMMIT	City
State	NJ	State
ZIP Code	07901	ZIPCode

Field	Value	IRS element (for citing)
Description Of Services	FUNDRAISING CONSULTING	DescriptionOfServices
Compensation	110025	Compensation

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	1	NumberOfContractorsGT100K
Federated Campaigns	333	FederatedCampaigns
Related Organizations	2501380	RelatedOrganizations
Government Grants	50000	GovernmentGrants
All Other Contributions	22851763	AllOtherContributions
Noncash Contributions	4030	NoncashContributions
Total Contributions	25403476	TotalContributions

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	925158	TotalRevenueColumn
Exclusion	$925,158	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	17940326	Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	17477648	Securities

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	462678	Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	462678	TotalRevenueColumn
Exclusion	$462,678	ExclusionAmount

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	26791312	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$1,387,836	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	14873020	Total
Program Services	14873020	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	437000	Total
Program Services	437000	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	989000	Total
Program Services	989000	ProgramServices

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	3143216	Total
Program Services	1279865	ProgramServices
Management And General	465227	ManagementAndGeneral
Fundraising	1398124	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	55619	Total
Management And General	55619	ManagementAndGeneral

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	110025	Total
Fundraising	110025	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	186324	Total
Management And General	186324	ManagementAndGeneral

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	180994	Total
Management And General	130944	ManagementAndGeneral
Fundraising	50050	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	47379	Total
Management And General	32050	ManagementAndGeneral
Fundraising	15329	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	17122	Total
Program Services	565	ProgramServices
Management And General	5541	ManagementAndGeneral
Fundraising	11016	Fundraising

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	231180	Total
Management And General	231180	ManagementAndGeneral

Travel Travel

Field	Value	IRS element (for citing)
Total	220929	Total
Program Services	44942	ProgramServices
Management And General	137988	ManagementAndGeneral
Fundraising	37999	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	112942	Total
Program Services	8964	ProgramServices
Management And General	76579	ManagementAndGeneral
Fundraising	27399	Fundraising

Other Expenses OtherExpenses (4 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
POSTAGE	65798	146	17826	47826
DUES & SUBSCRIPTIONS	63297		61985	1312
BANK & CREDIT CARD FEES	13361		13361
ALLOCATION OF ADMINISTR	0	305236	-640996	335760

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	20747206	Total
Program Services	17938738	ProgramServices
Management And General	773628	ManagementAndGeneral
Fundraising	2034840	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	4575939	BOY
EOY	1688633	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	668951	BOY
EOY	818610	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	6883142	BOY
EOY	8963175	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	81934	BOY
EOY	47886	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	24760586	BOY
EOY	31865247	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	9936	BOY
EOY	0	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	36980488	BOY
EOY	43383551	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	6381439	BOY
EOY	4825295	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	1684113	BOY
EOY	1027475	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	565454	BOY
EOY	2377675	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	8631006	BOY
EOY	8230445	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	18703836	BOY
EOY	23413565	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	9558405	BOY
EOY	9135100	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	87241	BOY
EOY	2604441	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	28349482	BOY
EOY	35153106	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	36980488	BOY
EOY	43383551	EOY

Field	Value	IRS element (for citing)
Reconcilation Revenue Expenses	6044106	ReconcilationRevenueExpenses
Reconciliation Unrealized Invest	759518	ReconciliationUnrealizedInvest
Reconcilation Other Changes	0	ReconcilationOtherChanges
Info In Schedule O Part XII	X	InfoInScheduleOPartXII
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited

FS Audited Basis FSAuditedBasis

Field	Value	IRS element (for citing)
Financial Statement Both	X	FinancialStatementBoth

Field	Value	IRS element (for citing)
Audit Committee	1	AuditCommittee
Federal Grant Audit Required	0	FederalGrantAuditRequired

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	32873924	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	24169849	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	24400007	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	23206830	CurrentTaxYearMinus1Year
Current Tax Year	25403476	CurrentTaxYear
Total	130054086	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	32873924	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	24169849	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	24400007	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	23206830	CurrentTaxYearMinus1Year
Current Tax Year	25403476	CurrentTaxYear
Total	130054086	Total

Field	Value	IRS element (for citing)
Amounts Subst Contributors Total	49260444	AmountsSubstContributorsTotal
Public Support Total170	80793642	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	481663	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	195182	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	136059	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	595807	CurrentTaxYearMinus1Year
Current Tax Year	925158	CurrentTaxYear
Total	2333869	Total

Field	Value	IRS element (for citing)
Total Support	132387955	TotalSupport
Public Support Pertcentage170	0.61030	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.58640	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule D IRS990ScheduleD

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	82699	BeginningOfYearBalance
Contributions	2517200	Contributions
Investment Earnings Or Losses	7627	InvestmentEarningsOrLosses
Grants Or Scholarships	2200	GrantsOrScholarships
End Of Year Balance	2605326	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	82241	BeginningOfYearBalance
Contributions	5000	Contributions
Investment Earnings Or Losses	-2594	InvestmentEarningsOrLosses
Grants Or Scholarships	1948	GrantsOrScholarships
End Of Year Balance	82699	EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	116963	BeginningOfYearBalance
Contributions	15930	Contributions
Investment Earnings Or Losses	1348	InvestmentEarningsOrLosses
Grants Or Scholarships	52000	GrantsOrScholarships
End Of Year Balance	82241	EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	103356	BeginningOfYearBalance
Contributions	14492	Contributions
Investment Earnings Or Losses	1115	InvestmentEarningsOrLosses
Grants Or Scholarships	2000	GrantsOrScholarships
End Of Year Balance	116963	EndOfYearBalance

Current Year Minus4 Years CurrentYearMinus4Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	154283	BeginningOfYearBalance
Investment Earnings Or Losses	6573	InvestmentEarningsOrLosses
Grants Or Scholarships	57500	GrantsOrScholarships
End Of Year Balance	103356	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.00000	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	1.00000	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.00000	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	0	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	0	EndowmentsHeldByRelatedOrgs
Total Of Book Value Land Buildings	0	TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	DUE TO RELATED ORGANIZATION	Description
Amount	$2,377,675	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	2377675	TotalOfAmounts
Footnote In Part XIII	X	FootnoteInPartXIII
Tot Revenue Etc Audited Fincl Stmt	27364507	TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments	759519	NetUnrealizedGainsInvestments
Revenue Not Rptd F990	759519	RevenueNotRptdF990
Revenue Subtotal	26604988	RevenueSubtotal
Investment Expenses Not Included	186324	InvestmentExpensesNotIncluded
Revenue Not Rptd On Fin Stmt	186324	RevenueNotRptdOnFinStmt
Total Revenue Per Form990	26791312	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	20560882	TotExpensesEtcAuditedFinclStmt
Expenses Not Rptd F990	0	ExpensesNotRptdF990
Expenses Subtotal	20560882	ExpensesSubtotal
Investment Expenses Not Included2	186324	InvestmentExpensesNotIncluded2
Expenses Not Rptd On Fin Stmt	186324	ExpensesNotRptdOnFinStmt
Total Expenses Per Form990	20747206	TotalExpensesPerForm990

Form990 Schedule D Part XIII Form990ScheduleDPartXIII (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:	PART V, LINE 4:	PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. PART V, LINE 1A-1G: ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:	PART X, LINE 2:	THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2009 THROUGH 2012 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
		PART IV; QUESTION 4 - INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)

RegionRegion	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
NORTH AMERICA	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES	YOUNG INVESTIGATOR AWARD ($50,000) AND CAREER DEVELOPMENT AWARD ($400,000)	450000
EAST ASIA & THE PACIFIC	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES	MERIT AWARDS ($6,000) AND ADVANCED CLINICAL RESEARCH AWARD ($450,000)	456000
EUROPE	GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES	MERIT AWARDS ($31,500) AND YOUNG INVESTIGATOR AWARD ($50,000)	81500
RUSSIA & THE NEWLY INDEPENDENT STATES	GRANTS ISSUED TO INDIVIDUAL, PROGRAM SERVICES	MERIT AWARD ($1,500)	1500

Field	Value	IRS element (for citing)
Subtotal Number Of Offices	0	SubtotalNumberOfOffices
Subtotal Number Of Employees	0	SubtotalNumberOfEmployees
Cont Number Of Offices	0	ContNumberOfOffices
Cont Number Of Employees	0	ContNumberOfEmployees
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	0	TotalNumberOfEmployees
Subtotal Amount Spent	989000	SubtotalAmountSpent
Cont Amount Spent	0	ContAmountSpent
Total Amount Spent	989000	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (5 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant
EAST ASIA & THE PACIFIC	ADVANCED CLINICAL RESEARCH AWARD (ACRA)	450000
NORTH AMERICA	YOUNG INVESTIGATOR AWARD (YIA)	50000
NORTH AMERICA	CAREER DEVELOPMENT AWARD (CDA)	200000
NORTH AMERICA	CAREER DEVELOPMENT AWARD (CDA)	200000
EUROPE	YOUNG INVESTIGATOR AWARD (YIA)	50000

Field	Value	IRS element (for citing)
Total Number Of Other Orgs	5	TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (3 entries)

Type Of AssistanceTypeOfAssistance	RegionRegion	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EAST ASIA & PACIFIC	4	6000
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	EUROPE	21	31500
AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.	RUSSIA & THE NEWLY INDEPENDENT STATES	1	1500

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorp
Interest In Foreign Trust	0	InterestInForeignTrust
Own Foreign Corp	0	OwnForeignCorp
Passive Foreign Invest Co	0	PassiveForeignInvestCo
Foreign Partnership	0	ForeignPartnership
Boycott Countries	0	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:	Identifier
Explanation	SCHEDULE F, PART I, LINE 2: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST FOR A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.	Explanation

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
Phone Solicitations	X	PhoneSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

Field	Value	IRS element (for citing)
Name Of Individual	GRAHAM PELTON	NameOfIndividual

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	39 BEACHWOOD RD	AddressLine1
City	SUMMIT	City
State	NJ	State
ZIP Code	07901	ZIPCode

Field	Value	IRS element (for citing)
Activity	FUNDRAISING CONSULTING	Activity
Fundraiser Control Of Funds	0	FundraiserControlOfFunds
Gross Receipts	0	GrossReceipts
Amount Retained By Contractor	110025	AmountRetainedByContractor
Net To Organization	-110025	NetToOrganization

Field	Value	IRS element (for citing)
Total Retained By Contractors	110025	TotalRetainedByContractors
Total Net To Organization	-110025	TotalNetToOrganization
Licensed States	AL	LicensedStates
Licensed States	AK	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	DE	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	ID	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	IN	LicensedStates
Licensed States	IA	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	LA	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	MT	LicensedStates
Licensed States	NE	LicensedStates
Licensed States	NV	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	SD	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	TX	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	VT	LicensedStates
Licensed States	VA	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	WV	LicensedStates
Licensed States	WI	LicensedStates
Licensed States	WY	LicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

Field	Value	IRS element (for citing)
Identifier	EXPLANATION OF FUNDRAISING PAYMENTS	Identifier
Return Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	ReturnReference
Explanation	PAYMENTS MADE TO GRAHAM PELTON CONSULTING WERE FOR FUNDRAISING GUIDANCE ON BEST PRACTICE METHODS OF EFFECTIVE AND EFFICIENT FUNDRAISING. CCF'S RELATED ORGANIZATION, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO), ALSO PAID COSTS FOR FUNDRAISING SERVICES PROVIDED TO CCF, WHICH ARE REFLECTED IN THE IRS FORM 990 OF ASCO.	Explanation

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (36 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant	Address Line2AddressUS/AddressLine2
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA	HOUSTON	TX	77030	741613878	501 (C)(3)	165000	LONG-TERM INTERNATIONAL FELLOWSHIP, YOUNG INVESTIGATOR AWARD
CASE WESTERN RESERVE UNIVERSITY
11100 EUCLID AVE	CLEVELAND	OH	44106	341018992	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVE	CINCINNATI	OH	45229	310833936	501 (C)(3)	200000	CAREER DEVELOPMENT AWARD
DUKE UNIVERSITY MEDICAL CENTER
BOX 2714	DURHAM	NC	27710	560532129	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
DANA-FARBER CANCER INSTITUTE
44 BINNEY STREET BP431C	BOSTON	MA	02115	042263040	501 (C)(3)	400000	YOUNG INVESTIGATOR AWARDS, CAREER DEVELOPMENT AWARDS
LOYOLA UNIVERSITY OF CHICAGO
1032 W SHERIDAN RD	CHICAGO	IL	60660	361408475	501 (C)(3)	8500	MEDICAL STUDENT ROTATION AWARD
MDDC SOCIETY OF CLINICAL ONCOLOGY
550M RITCHIE HIGHWAY	SEVERNA PARK	MD	21146	521833721	501 (C)(3)	10000	STATE AFFILIATE GRANT PROGRAM
JOHNS HOPKINS UNIVERSITY
550 NORTH BROAKWAY SUITE 1003	BALTIMORE	MD	212052009	520591627	501 (C)(3)	200000	YOUNG INVESTIGATOR AWARDS
MOREHOUSE SCHOOL OF MEDICINE
720 WESTVIEW DR SW	ATLANTA	GA	30310	158143886	GOV'T UNIT	8500	MEDICAL STUDENT ROTATION AWARD
NYU SCHOOL OF MEDICINE
550 FIRST AVE	NEW YORK	NY	10016	135562309	GOV'T UNIT	50000	YOUNG INVESTIGATOR AWARD
MEMORIAL SLOAN-KETTERING CANCER CENTER
GENERAL POST OFFICE BOX 263633	NEW YORK	NY	10017	131924236	501 (C)(3)	1100000	YOUNG INVESTIGATOR AWARDS, CAREER DEVELOPMENT AWARDS, GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP	THIRD AVE
GEORGIA SOCIETY OF CLINICAL ONCOLOGY
3330 CUMBERLAND BLVD	ATLANTA	GA	30339	581752866	501 (C)(6)	10000	STATE AFFILIATE GRANT PROGRAM
NORTHERN NEW ENGLAND CLINICAL ONCOLOGY SOCIETY
PO BOX 643	SANDOWN	NH	03873	204450555	501 (C)(3)	10000	STATE AFFILIATE GRANT PROGRAM
OHIO STATE UNIVERSITY
901 WOODY HAYES DR	COLUMBUS	OH	43210	890330467	GOV'T UNIT	165000	YOUNG INVESTIGATOR AWARDS, LONG-TERM INTERNATIONAL FELLOWSHIP
ROSWELL PARK CANCER INSTITUTE
ELM CARLTON STREETS	BUFFALO	NY	14263	141402155	501 (C)(3)	500000	DRUG DEVELOPMENT RESEARCH PROFESSORSHIP
SEATTLE CHILDRENS HOSPITAL
1100 OLIVE WAY	SEATTLE	WA	98101	910564748	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF CALIFORNIA - SAN FRANCISCO
3333 CALIFORNIA STREET	SAN FRANCISCO	CA	94118	942829914	501 (C)(3)	200000	YOUNG INVESTIGATOR AWARDS
STANFORD UNIVERSITY
800 WELCH ROAD	STANFORD	CA	94305	911825354	501 (C)(3)	150000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF CALIFORNIA - SAN DIEGO
3855 HEALTH SCIENCE DRIVE	LA JOLLA	CA	92093	956006144	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
MEDICAL UNIVERSITY OF SOUTH CAROLINA
86 JONATHAN LUCAS STREET	CHARLESTON	SC	29425	576000722	GOV'T UNIT	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE
6850 LAKE NONA BLVD	ORLANDO	FL	32827	592924020	GOV'T UNIT	17000	MEDICAL STUDENT ROTATION AWARDS
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4486	HOUSTON	TX	77210	746000203	GOV'T UNIT	500000	CAREER DEVELOPMENT AWARDS, YOUNG INVESTIGATOR AWARDS
UNIVERSITY OF KANSAS MEDICAL CENTER
3901 RAINBOW RD	KANSAS CITY	KS	66160	148602992	GOV'T UNIT	8500	MEDICAL STUDENT ROTATION AWARD
UNC AT CHAPEL HILL
102 MASON FARM RD	CHAPEL HILL	NC	27599	566001393	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF PITTSBURGH
3100 CATHEDRAL OF LEARNING	PITTSBURGH	PA	15260	125096559	GOV'T UNIT	8500	MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF PENNSYLVANIA
3400 SPRUCE ST	PHILADELPHIA	PA	19104	231352685	501 (C)(3)	108500	YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF TEXAS SWESTERN
5323 HARRY HINES BLVD	DALLAS	TX	75390	756002868	GOV'T UNIT	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF ROCHESTER
910 GENESEE ST SUITE 200	ROCHESTER	NY	146113847	160743209	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARDS
UNIVERSITY OF SOUTHERN CALIFORNIA
1441 EASTLAKE AVE	LOS ANGELES	CA	90089	951642394	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
WASHINGTON UNIVERSITY ST LOUIS
700 ROSEDALE AVE	ST LOUIS	MO	63112	430653611	501 (C)(3)	8500	MEDICAL STUDENT ROTATION AWARD
YALE UNIVERSITY
333 CEDAR ST	NEW HAVEN	CT	06520	060646973	501 (C)(3)	50000	YOUNG INVESTIGATOR AWARD
MASSACHUSETTS GENERAL HOSPITAL
555 FRUIT STREET	BOSTON	MA	02114	041564655	501 (C)(3)	300000	CAREER DEVELOPMENT AWARD, YOUNG INVESTIGATOR AWARDS
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1802 SIXTH AVE SOUTH	BIRMINGHAM	AL	35294	636005396	GOV'T UNIT	50000	YOUNG INVESTIGATOR AWARD
UNIVERSITY OF MARYLAND
22 SOUTH GREENE STREET	BALTIMORE	MD	21201	521362753	GOV'T UNIT	8500	MEDICAL STUDENT ROTATION AWARD
UNIVERSITY OF WISCONSIN
600 HIGHLAND AVE	MADISON	WI	53792	396006492	GOV'T UNIT	58500	YOUNG INVESTIGATOR AWARD, MEDICAL STUDENT ROTATION AWARD
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2318 MILL RD 800	ALEXANDRIA	VA	22314	136180380	501 (C)(3)	9951001	CONTRIBUTION

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	35	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	1	TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (4 entries)

Type Of GrantTypeOfGrant	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant
GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE	1	10000
MERIT AWARDS	194	222000
PATIENT ADVOCATE SCHOLARSHIPS	72	134000
ONCOLOGY TRAINEE TRAVEL AWARDS	17	21000

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS IN THE U.S.:	Identifier
Return Reference	PART I, LINE 2:	ReturnReference
Explanation	SCHEDULE I, PART I, LINE 2: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST FOR A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Severance Payment	0	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	0	AnyNonFixedPayments
Initial Contract Exception	0	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (4 entries)

TitleTitle	Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
ALLEN S LICHTER MD FASCO
CEO	0	669040	0	95000	0	15000	0	18750	0	1874	0	799664	0	0
NANCY DALY MS MPH
EXECUTIVE DIRECTOR	0	205986	0	6326	0	0	0	15763	0	14387	0	242462	0	0
DINA MICHELS ESQ
GENERAL COUNSEL	0	473165	0	0	0	0	0	18750	0	19464	0	511379	0	0
PAUL AINES CPA
CFO	0	294127	0	6000	0	0	0	18750	0	18542	0	337419	0	0

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (8 entries)

Return ReferenceReturnReference	ExplanationExplanation
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2012, THE BOARD OF DIRECTORS OF CCF INCLUDED FOURTEEN (14) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. THIRTEEN (13) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO) A NON-PROFIT, 501(C)(3) TAX EXEMPT ORGANIZATION, A RELATED ORGANIZATION. THERE WERE THREE EX OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. ONE VOTING MEMBER OF CCF'S BOARD OF DIRECTORS DOES NOT MEET THE DEFINITIONAL TEST OF AN INDEPENDENT MEMBER OF CCF'S GOVERNING BODY: ALLEN LICHTER, M.D. IS AN EX-OFFICIO, VOTING MEMBER OF CCF'S BOARD OF DIRECTORS WHO SERVES AS THE CEO OF CCF AND THE CEO OF ASCO (A RELATED ORGANIZATION OF CCF). HE IS AN EMPLOYEE OF ASCO AND RECEIVED COMPENSATION FROM ASCO. CONSISTENT WITH CCF'S BYLAWS, DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 7A	CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.
FORM 990, PART VI, SECTION A, LINE 7B	THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CHIEF EXECUTIVE OFFICER, AND THE GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CCF IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CCF DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF. INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO.
FORM 990, PART VI, SECTION C, LINE 19	CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CCF ARE POSTED ON CCF'S WEBSITE.
FORM 990, PART XII, LINE 2C	THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
EIN	136180380	EIN
Primary Activities	SUPPORTS CANCER RESEARCH, EDUCATION AND QUALITY IMPROVEMENT PROGRAMS	PrimaryActivities
Legal Domicile State	NY	LegalDomicileState
Exempt Code Section	501(C)(3)	ExemptCodeSection
Public Charity Status	LINE 9	PublicCharityStatus
Direct Controlling Entity NA	N/A	DirectControllingEntityNA
Controlled Org	0	ControlledOrg

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	0	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	1	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	1	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	1	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	0	LoansOrGuaranteesFromOtherOrg
Dividends Related Organization	0	DividendsRelatedOrganization
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	0	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	1	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	1	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	0	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	1	SharingOfPaidEmployees
Reimbursement Paid To Other Org	1	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	1	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	0	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (8 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved	Method Of Amt DeterminationMethodOfAmtDetermination
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
B	9951001	FMV
ASCO
C	764000	FMV
ASCO
D	64000000	FMV
ASCO
K	231180	FMV
ASCO
L	2034840	FMV
ASCO
O	3143216	FMV
ASCO
P	5226278	FMV
ASCO
Q	2603551	FMV